These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8750251)

  • 1. Effects of lipid-lowering therapy on total and coronary mortality.
    Holme I
    Curr Opin Lipidol; 1995 Dec; 6(6):374-8. PubMed ID: 8750251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease.
    Olsson AG; Pedersen T; Bergdahl B
    Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.
    de Faire U; Ericsson CG; Grip L; Nilsson J; Svane B; Hamsten A
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():257-63. PubMed ID: 9211018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering therapy for patients with or at risk of coronary artery disease.
    Kjekshus J; Pedersen TR; Tobert JA
    Curr Opin Cardiol; 1996 Jul; 11(4):418-27. PubMed ID: 8879953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol reduction and its impact on coronary artery disease and total mortality.
    Holme I
    Am J Cardiol; 1995 Sep; 76(9):10C-17C. PubMed ID: 7572677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the most of cholesterol-lowering margarines.
    Avery JK
    Cleve Clin J Med; 2001 Mar; 68(3):194-6. PubMed ID: 11263847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of cholesterol-lowering therapy: coronary angiographic and events trials.
    Waters D; Pedersen TR
    Am J Med; 1996 Oct; 101(4A):4A34S-38S; discussion 39S. PubMed ID: 8900335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of recent large cholesterol-lowering trials and implications for clinical management.
    Gotto AM
    Am J Cardiol; 1997 Jun; 79(12):1663-6. PubMed ID: 9202359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).
    Bestehorn HP; Rensing UF; Roskamm H; Betz P; Benesch L; Schemeitat K; Blümchen G; Claus J; Mathes P; Kappenberger L; Wieland H; Neiss A
    Eur Heart J; 1997 Feb; 18(2):226-34. PubMed ID: 9043838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease.
    Rackley CE
    Clin Cardiol; 1996 Sep; 19(9):683-9. PubMed ID: 8874986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?
    Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G
    Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging.
    Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Smith D; Weinberger J; Wentzel J; Mizsei G; Mercuri M; Badimon JJ
    Circulation; 2002 Dec; 106(23):2884-7. PubMed ID: 12460866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.
    Cook JR; Yin D; Alemao E; Drummond M
    Pharmacoeconomics; 2004; 22 Suppl 3():37-48. PubMed ID: 15669152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.